Breaking News Instant updates and real-time market news.

CMTL

Comtech

$20.64 /

+0.09 (+0.44%)

, ACTG

Acacia Research

$4.33 /

-0.01 (-0.23%)

08:49
01/25/22
01/25
08:49
01/25/22
08:49

Comtech board rejects Acacia Research proposal to acquire the company

Comtech (CMTL) announced that the company's board of directors has unanimously rejected the unsolicited proposal to acquire Comtech received from Acacia Research (ACTG) on October 29, 2021. The Comtech board of directors, including the recently appointed members, carefully evaluated the proposal in consultation with the board's independent advisors and determined that the proposal undervalues the company and is not in the best interests of Comtech's shareholders. The company said, "The Comtech Board's unanimous conclusion regarding the inadequacy of Acacia's proposal is based on the following key considerations: Comtech has made strategic investments in innovative technologies that position the Company to capitalize on large, long-term renewal cycles in the 911 public safety and satellite and space communication markets. Structural changes in these markets are expected to drive significant long-term growth driven by multi-year investment cycles that are well-aligned with Comtech's core capabilities, products, and services. Comtech is already beginning to see the long-term benefits of these investments and end market trends, which have created a number of large-scale opportunities being pursued by the Company. As such, the Company's Board and management remain highly confident in Comtech's long-term business outlook and believe the Company is well positioned to create significant value for its shareholders. Based on the foregoing considerations, among others, the Board unanimously determined that the non-binding Acacia proposal grossly undervalues the Company, does not reflect the transformational changes underway in the Company's end-markets and the significant inherent value in the Company's plan, and, thus, is not in the best interests of the Company and its shareholders."

CMTL

Comtech

$20.64 /

+0.09 (+0.44%)

ACTG

Acacia Research

$4.33 /

-0.01 (-0.23%)

OTHER BREAKING NEWS FROM THE FLY

Upgrade
Elior Group upgraded to Hold from Sell at Stifel » 04:59
12/06/22
12/06
04:59
12/06/22
04:59
ELROF

Elior Group

$2.85 /

+ (+0.00%)

Stifel analyst Simon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELROF Elior Group
$2.85 /

+ (+0.00%)

11/14/22 Barclays
Elior Group downgraded to Underweight from Equal Weight at Barclays
11/11/22 UBS
Elior Group price target lowered to EUR 3 from EUR 3.30 at UBS
10/05/22 Deutsche Bank
Elior Group price target lowered to EUR 2.20 from EUR 2.50 at Deutsche Bank
09/26/22 JPMorgan
Elior Group price target lowered to EUR 2 from EUR 2.50 at JPMorgan
Downgrade
Bankinter downgraded to Underweight from Neutral at JPMorgan » 04:57
12/06/22
12/06
04:57
12/06/22
04:57
BKIMF

Bankinter

$6.50 /

+ (+0.00%)

JPMorgan analyst Sofie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BKIMF Bankinter
$6.50 /

+ (+0.00%)

10/24/22 Berenberg
Bankinter price target raised to EUR 7 from EUR 5.70 at Berenberg
10/21/22 JPMorgan
Bankinter price target raised to EUR 5.60 from EUR 5.50 at JPMorgan
10/21/22 Societe Generale
Bankinter price target raised to EUR 6 from EUR 5.90 at Societe Generale
10/18/22 Deutsche Bank
Bankinter price target lowered to EUR 5.95 from EUR 6.05 at Deutsche Bank
Downgrade
Societe Generale downgraded to Neutral from Overweight at JPMorgan » 04:56
12/06/22
12/06
04:56
12/06/22
04:56
SCGLY

Societe Generale

$4.75 /

-0.12 (-2.46%)

JPMorgan analyst Kian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCGLY Societe Generale
$4.75 /

-0.12 (-2.46%)

SCGLY Societe Generale
$4.75 /

-0.12 (-2.46%)

11/18/22 Morgan Stanley
Societe Generale downgraded to Equal Weight from Overweight at Morgan Stanley
11/07/22 JPMorgan
Societe Generale price target lowered to EUR 33 from EUR 34 at JPMorgan
11/07/22 Deutsche Bank
Societe Generale price target raised to EUR 37 from EUR 34 at Deutsche Bank
11/02/22 Barclays
Societe Generale price target lowered to EUR 40 from EUR 42.30 at Barclays
SCGLY Societe Generale
$4.75 /

-0.12 (-2.46%)

SCGLY Societe Generale
$4.75 /

-0.12 (-2.46%)

Conference/Events
Fiverr management to meet with Piper Sandler » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
FVRR

Fiverr

$32.28 /

-1.585 (-4.68%)

Meeting to be held in San…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FVRR Fiverr
$32.28 /

-1.585 (-4.68%)

FVRR Fiverr
$32.28 /

-1.585 (-4.68%)

11/10/22 Oppenheimer
Fiverr price target lowered to $40 from $50 at Oppenheimer
11/09/22 Piper Sandler
Fiverr margin expansion story 'very much on track,' says Piper Sandler
08/05/22 Needham
Fiverr price target raised to $50 from $40 at Needham
08/04/22 Piper Sandler
Piper Sandler applauds strategic pivot at Fiverr, keeps $50 target
FVRR Fiverr
$32.28 /

-1.585 (-4.68%)

FVRR Fiverr
$32.28 /

-1.585 (-4.68%)

Conference/Events
Truist leisure/lodging analyst holds an analyst/industry conference call » 04:55
12/06/22
12/06
04:55
12/06/22
04:55

Lodging & Leisure…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
PlayAGS management to meet with B. Riley » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
AGS

PlayAGS

$5.23 /

-0.13 (-2.43%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGS PlayAGS
$5.23 /

-0.13 (-2.43%)

AGS PlayAGS
$5.23 /

-0.13 (-2.43%)

08/09/22 B. Riley
PlayAGS price target raised to $14 from $12 at B. Riley
08/01/22 Stifel
PlayAGS price target lowered to $9 from $11 at Stifel
07/20/22 Truist
PlayAGS price target lowered to $12 from $13 at Truist
07/14/22 Deutsche Bank
PlayAGS price target lowered to $11 from $12 at Deutsche Bank
AGS PlayAGS
$5.23 /

-0.13 (-2.43%)

  • 15
    Nov
AGS PlayAGS
$5.23 /

-0.13 (-2.43%)

AGS PlayAGS
$5.23 /

-0.13 (-2.43%)

Conference/Events
LKQ Corp. management to meet with Barrington » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
LKQ

LKQ Corp.

$53.97 /

-1.07 (-1.94%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LKQ LKQ Corp.
$53.97 /

-1.07 (-1.94%)

LKQ LKQ Corp.
$53.97 /

-1.07 (-1.94%)

07/12/22 MKM Partners
LKQ Corp. initiated with a Buy at MKM Partners
04/28/22 Barrington
LKQ Corp. upgraded to Outperform at Barrington after beat and raise report
04/28/22 Barrington
LKQ Corp. upgraded to Outperform from Market Perform at Barrington
04/11/22 Raymond James
LKQ Corp. price target lowered to $59 from $62 at Raymond James
LKQ LKQ Corp.
$53.97 /

-1.07 (-1.94%)

Conference/Events
Newmark management to meet with Piper Sandler » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
NMRK

Newmark

$8.48 /

-0.135 (-1.57%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NMRK Newmark
$8.48 /

-0.135 (-1.57%)

NMRK Newmark
$8.48 /

-0.135 (-1.57%)

10/07/22 Piper Sandler
Newmark price target lowered to $10 from $12 at Piper Sandler
04/18/22 Piper Sandler
Newmark downgraded to Neutral from Overweight at Piper Sandler
04/05/22 Goldman Sachs
Newmark initiated with a Neutral at Goldman Sachs
03/10/22 Wolfe Research
Newmark downgraded to Peer Perform from Outperform at Wolfe Research
NMRK Newmark
$8.48 /

-0.135 (-1.57%)

NMRK Newmark
$8.48 /

-0.135 (-1.57%)

Conference/Events
Matson management to meet virtually with Stephens » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
MATX

Matson

$61.60 /

-2.89 (-4.48%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
MATX Matson
$61.60 /

-2.89 (-4.48%)

MATX Matson
$61.60 /

-2.89 (-4.48%)

11/17/22 Wolfe Research
Wolfe reshuffles ratings in freight with five downgrades and one upgrade
11/17/22 Wolfe Research
Matson upgraded to Peer Perform from Underperform at Wolfe Research
10/20/22 Stifel
Matson price target lowered to $81 from $93 at Stifel
08/16/22 Wolfe Research
Wolfe starts Matson at Underperform, sees 'peak EPS' in 2022
MATX Matson
$61.60 /

-2.89 (-4.48%)

MATX Matson
$61.60 /

-2.89 (-4.48%)

Conference/Events
Candel Therapeutics to host a virtual research and development day » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
CADL

Candel Therapeutics

$1.97 /

+0.08 (+4.23%)

Virtual Research and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
CADL Candel Therapeutics
$1.97 /

+0.08 (+4.23%)

CADL Candel Therapeutics
$1.97 /

+0.08 (+4.23%)

12/02/22 H.C. Wainwright
Candel Therapeutics initiated with a Buy at H.C. Wainwright
03/31/22 BMO Capital
Candel Therapeutics price target lowered to $12 from $18 at BMO Capital
CADL Candel Therapeutics
$1.97 /

+0.08 (+4.23%)

Conference/Events
Editas Medicine to host conference call » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
EDIT

Editas Medicine

$9.83 /

-0.425 (-4.15%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

12/05/22 Credit Suisse
Editas Medicine assumed with a Neutral at Credit Suisse
11/18/22 Morgan Stanley
Editas Medicine price target lowered to $8 from $10 at Morgan Stanley
11/18/22 BofA
Editas' EDIT-101 setback 'not the end of the story,' says BofA
11/18/22 RBC Capital
Editas Medicine price target lowered to $14 from $32 at RBC Capital
EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

EDIT Editas Medicine
$9.83 /

-0.425 (-4.15%)

Conference/Events
Century Communities management to meet virtually with BTIG » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
CCS

Century Communities

$49.58 /

-1.54 (-3.01%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCS Century Communities
$49.58 /

-1.54 (-3.01%)

CCS Century Communities
$49.58 /

-1.54 (-3.01%)

11/29/22 BTIG
Century Communities initiated with a Neutral at BTIG
11/22/22 JPMorgan
Century Communities downgraded to Underweight from Overweight at JPMorgan
10/27/22 B. Riley
Century Communities downgraded on margin headwinds at B. Riley
10/27/22 B. Riley
Century Communities downgraded to Neutral from Buy at B. Riley
CCS Century Communities
$49.58 /

-1.54 (-3.01%)

Conference/Events
iCAD management to meet virtually with BTIG » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
ICAD

iCAD

$1.74 /

-0.08 (-4.40%)

Medical Technology and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ICAD iCAD
$1.74 /

-0.08 (-4.40%)

ICAD iCAD
$1.74 /

-0.08 (-4.40%)

11/29/22 Lake Street
Google Health partnership 'significant positive' for iCAD, says Lake Street
11/28/22 JMP Securities
JMP views iCAD agreement with Google Health 'very favorably'
11/11/22 Lake Street
iCAD price target lowered to $5 from $8 at Lake Street
09/01/22 JMP Securities
iCAD price target lowered to $7 from $13 at JMP Securities
ICAD iCAD
$1.74 /

-0.08 (-4.40%)

Conference/Events
DMC Global management to meet with KeyBanc » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
BOOM

DMC Global

$17.47 /

-1.035 (-5.59%)

Meetings to be held with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOOM DMC Global
$17.47 /

-1.035 (-5.59%)

BOOM DMC Global
$17.47 /

-1.035 (-5.59%)

09/14/22
DMC Global management to meet with Roth Capital
05/03/22 Roth Capital
DMC Global price target lowered to $35 from $50 at Roth Capital
12/23/21 Stifel
DMC Global price target raised to $48 from $46 at Stifel
BOOM DMC Global
$17.47 /

-1.035 (-5.59%)

Conference/Events
Dynatronics management to meet virtually with Lake Street » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
DYNT

Dynatronics

/

+

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DYNT Dynatronics
/

+

DYNT Dynatronics
/

+

07/27/22 Lake Street
Dynatronics initiated with a Buy at Lake Street
DYNT Dynatronics
/

+

DYNT Dynatronics
/

+

Conference/Events
Eagle Pharmaceuticals to host investor day » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
EGRX

Eagle Pharmaceuticals

$33.95 /

-1.9 (-5.30%)

Investor Day to be held…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EGRX Eagle Pharmaceuticals
$33.95 /

-1.9 (-5.30%)

EGRX Eagle Pharmaceuticals
$33.95 /

-1.9 (-5.30%)

12/16/21 Barclays
Endo price target lowered to $5 from $7 at Barclays
12/15/21 Cantor Fitzgerald
Vasopressin approval 'a key win' for Eagle Pharmaceuticals, says Cantor
EGRX Eagle Pharmaceuticals
$33.95 /

-1.9 (-5.30%)

Conference/Events
JPMorgan transports analyst to hold an analyst/industry conference call » 04:55
12/06/22
12/06
04:55
12/06/22
04:55

Transports Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

Conference/Events
Celldex to host conference call » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
CLDX

Celldex

$36.70 /

-0.665 (-1.78%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLDX Celldex
$36.70 /

-0.665 (-1.78%)

CLDX Celldex
$36.70 /

-0.665 (-1.78%)

10/10/22 Jefferies
Third Harmonic Bio initiated with a Buy at Jefferies
07/01/22 H.C. Wainwright
Celldex price target raised to $73 from $60 at H.C. Wainwright
CLDX Celldex
$36.70 /

-0.665 (-1.78%)

CLDX Celldex
$36.70 /

-0.665 (-1.78%)

CLDX Celldex
$36.70 /

-0.665 (-1.78%)

Conference/Events
Alphatec to participate in a conference call with Lake Street » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
ATEC

Alphatec

$9.75 /

-0.525 (-5.11%)

Key Opinion Leader…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATEC Alphatec
$9.75 /

-0.525 (-5.11%)

ATEC Alphatec
$9.75 /

-0.525 (-5.11%)

10/17/22 Lake Street
Alphatec price target raised to $16.50 from $13 at Lake Street
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
10/12/22 Jefferies
Alphatec initiated with a Buy at Jefferies
10/10/22 Piper Sandler
Piper Sandler bullish on Alphatec following Q3 preliminary results
ATEC Alphatec
$9.75 /

-0.525 (-5.11%)

ATEC Alphatec
$9.75 /

-0.525 (-5.11%)

ATEC Alphatec
$9.75 /

-0.525 (-5.11%)

Conference/Events
JPMorgan transportation/fuel analyst holds analyst/industry conference call » 04:55
12/06/22
12/06
04:55
12/06/22
04:55

Transportation/Fuel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
BTIG medical technology analyst to hold a group dinner » 04:55
12/06/22
12/06
04:55
12/06/22
04:55

Medical Tech &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
BTIG policy director to hold an analyst/industry conference call » 04:55
12/06/22
12/06
04:55
12/06/22
04:55

Policy Research Director…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Janus International Group management to meet with KeyBanc » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
JBI

Janus International Group

$10.75 /

-0.09 (-0.83%)

Meetings to be held with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JBI Janus International Group
$10.75 /

-0.09 (-0.83%)

JBI Janus International Group
$10.75 /

-0.09 (-0.83%)

09/06/22 CJS Securities
Janus International Group initiated with an Outperform at CJS Securities
01/26/22 Benchmark
Janus International Group initiated with a Buy at Benchmark
12/08/21 Stifel
Janus International Group initiated with a Buy at Stifel
12/07/21 UBS
Janus International Group initiated with a Neutral at UBS
JBI Janus International Group
$10.75 /

-0.09 (-0.83%)

JBI Janus International Group
$10.75 /

-0.09 (-0.83%)

Conference/Events
Comscore management to meet with Needham » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
SCOR

Comscore

$1.28 /

-0.085 (-6.23%)

Meetings to be held on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCOR Comscore
$1.28 /

-0.085 (-6.23%)

SCOR Comscore
$1.28 /

-0.085 (-6.23%)

03/23/22 Craig-Hallum
ComScore poised for share gains in local measurement, says Craig-Hallum
03/01/22 Truist
Comscore price target lowered to $3.50 from $4 at Truist
SCOR Comscore
$1.28 /

-0.085 (-6.23%)

Conference/Events
OmniAb to participate in a conference call with Benchmark » 04:55
12/06/22
12/06
04:55
12/06/22
04:55
OABI

OmniAb

$3.91 /

-0.06 (-1.51%)

Healthcare Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OABI OmniAb
$3.91 /

-0.06 (-1.51%)

OABI OmniAb
$3.91 /

-0.06 (-1.51%)

11/29/22 SVB Securities
OmniAb initiated with an Outperform at SVB Securities
11/28/22 Stifel
OmniAb initiated with a Buy at Stifel
10/25/22 H.C. Wainwright
Ligand target lowered to $135 at H.C. Wainwright after OmniAb deal approved
OABI OmniAb
$3.91 /

-0.06 (-1.51%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.